The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challenge

被引用文献1件参考文献43件

FERRANT Janine L.

Biogen Idec, Inc.
BENJAMIN Christopher D.

Biogen Idec, Inc.
CUTLER Anne H.

Biogen Idec, Inc.
KALLED Susan L.

Biogen Idec, Inc.
HSU Yen-Ming

Biogen Idec, Inc.
GARBER Ellen A.

Biogen Idec, Inc.
HESS Donna M.

Biogen Idec, Inc.
SHAPIRO Renee I.

Biogen Idec, Inc.
KENYON Norma S.

Diabetes Research Institute, University of Miami School of Medicine
HARLAN David M.

Transplantation and Autoimmunity Branch, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health
KIRK Allan D.

Transplantation and Autoimmunity Branch, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health
BURKLY Linda C.

Biogen Idec, Inc.
TAYLOR Frederick R.

Biogen Idec, Inc.

この論文をさがす

International immunology

International immunology 16 (11), 1583-1594, 2004-11-01